1986
DOI: 10.1111/j.1476-5381.1986.tb11152.x
|View full text |Cite
|
Sign up to set email alerts
|

Role of cyclic GMP in the modulation by endothelium of the adrenolytic action of prazosin in the rat isolated aorta

Abstract: 1 The effect ofendothelium on the adrenolytic action ofprazosin was studied in the rat isolated aorta. 2 Prazosin showed a non-competitive type of antagonism in preparations with intact endothelium while in preparations where endothelium had been removed, prazosin at concentrations between 0.3 nM-10 nM acted as a competitive antagonist. 3 Methylene blue, used to decrease tissue levels of guanosine 3': 5'-cyclic monophosphate (cyclic GMP), converted prazosin from a non-competitive antagonist into an apparently … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

1988
1988
1996
1996

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 34 publications
(15 citation statements)
references
References 29 publications
0
15
0
Order By: Relevance
“…It is known that, in certain blood vessels, removal of endothelium can potentiate the responses of vascular smooth muscle to AVP (Katusic & Krstic, 1987;Randall et al, 1988). In addition, it has been shown in numerous blood vessels that the endothelium-dependent modulation of agonistinduced contractile responses is related to release of relaxing factors from the endothelium, which in turn result in a reduction of agonist potency and efficacy (Alosachie & Godfraind, 1986;Pipili-Synetos et al, 1991;Adeagbo & Triggle, 1993). However, in the present study removal of the endothelium did not affect the response to AVP.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that, in certain blood vessels, removal of endothelium can potentiate the responses of vascular smooth muscle to AVP (Katusic & Krstic, 1987;Randall et al, 1988). In addition, it has been shown in numerous blood vessels that the endothelium-dependent modulation of agonistinduced contractile responses is related to release of relaxing factors from the endothelium, which in turn result in a reduction of agonist potency and efficacy (Alosachie & Godfraind, 1986;Pipili-Synetos et al, 1991;Adeagbo & Triggle, 1993). However, in the present study removal of the endothelium did not affect the response to AVP.…”
Section: Discussionmentioning
confidence: 99%
“…Recently we have reported that in rat isolated aorta, the modulation by endothelium of agonistinduced contractile response is related to an increase of cyclic GMP levels in vascular smooth muscles evoked by the release of EDRF, which in turn could result in a reduction of agonist efficacy and receptor reserve (Alosachie & Godfraind, 1986). This suggestion is in agreement with Malta et al (1986) and Martin et al (1986) who have also proposed a similar relation between endothelium modulation of agonist-induced contractile response and a possible I The Macmillan Press Ltd 1988 alteration of agonist efficacy by EDRF.…”
Section: Introductionmentioning
confidence: 99%
“…In order to compare the contribution of different a-adrenoceptor subtypes to the noradrenaline-induced contraction between vessels studied, we used prazosin, a predominantly mladrenoceptor antagonist (Cambridge et al, 1977;Starke, 1981;Skarby & Larsson, 1987) and yohimbine, a predominantly M2-adrenoceptor antagonist (Doxey et al, 1977;Ruffolo et al, 1981;Goldberg & Robertson, 1983). Although both antagonists are considered as competitive, Alosachie & Godfraind (1986 (Arunlakshana & Schild, 1959). It is known that the KB value for a specific antagonist acting on the same type of receptor in different preparations should be the same (Furchgott, 1972).…”
Section: Discussionmentioning
confidence: 99%